Emcure Pharma Shares Rise 7% After Q2 Profit Jumps 29%
Emcure Pharmaceuticals shares increased by up to 7.3% following a 29.3% year-on-year rise in Q2 FY27 profit to Rs 325.1 crore. The company's revenue grew 24.3%, and EBITDA rose 30.9%, driven by strong growth in its international business segment.
ET Markets·




